I.G. Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

I.G. Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-700,000	Closed	-$931K	–	940
2016 Q2	$931K	Buy	+700,000	New	+$3.27M	﹤0.01%	665
2016 Q1	–	Sell	-309,095	Closed	-$2.43M	–	947
2015 Q4	$2.43M	Sell	309,095 -23,105	-7%	-$199K	0.01%	458
2015 Q3	$2.81M	Sell	332,200 -31,551	-9%	-$291K	0.01%	417
2015 Q2	$3.98M	Buy	363,751 +265,000	+268%	+$3.4M	0.02%	399
2015 Q1	$1.38M	Sell	98,751 -50,000	-34%	-$764K	0.01%	574
2014 Q4	$2.51M	Sell	148,751 -156,700	-51%	-$2.28M	0.01%	447
2014 Q3	$4.1M	Sell	305,451 -4,000	-1%	-$47.6K	0.01%	365
2014 Q2	$3.94M	Buy	309,451 +38,701	+14%	+$403K	0.01%	379
2014 Q1	$3.22M	Buy	270,750 +35,400	+15%	+$475K	0.01%	388
2013 Q4	$3.25M	Sell	235,350 -50,650	-18%	-$715K	0.01%	384
2013 Q3	$4.99M	Buy	286,000 +20,000	+8%	+$383K	0.02%	331
2013 Q2	$4.32M	Buy	+266,000	New	+$8.23M	0.02%	345

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

I.G. Investment Management's INFI Position: Q3 2016 in Review

I.G. Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2016, closing a stake of 700,000 shares — an estimated $931K sold.

I.G. Investment Management first reported a position in INFI in Q2 2013 and held it in 12 quarters. The position peaked at $4.99M in Q3 2013. 99 funds tracked by Wall St. Rank hold INFI as of Q3 2016.

I.G. Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
I.G. Investment Management sold 700,000 Infinity Pharmaceuticals, Inc. shares in Q3 2016, an estimated $931K.
I.G. Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
I.G. Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $4.99M in Q3 2013.
99 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2016.

Based on I.G. Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.